Effectivness of a shortened cycle of monoimmunotherapy in NSCLC.

e21179Background: Monoimmunotherapy for NSCLC is performed in all patients with a high level of PD-L1 expression ( > 50%) or patients with severe comorbidity and contraindications to therapy with p...